Revenue | ₹848.89Cr |
Net Profits | ₹205.01Cr |
Net Profit Margins | 24.15% |
Glaxosmithkline Pharmaceuticals Ltd’s revenue fell -0.16% since last year same period to ₹848.89Cr in the Q1 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -16.37% fall in its revenue since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 12.44% since last year same period to ₹205.01Cr in the Q1 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -22.01% fall in its net profits since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 12.62% since last year same period to 24.15% in the Q1 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -6.75% fall in its net profit margins since last 3-months.
The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2025 was ₹848.89Cr.
The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2025 was ₹205.01Cr.
The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2025 was 24.15%.
The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2024 was ₹850.29Cr.
The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2024 was ₹182.33Cr.
The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2024 was 21.44%.